KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Change in Receivables (2020 - 2026)

Boston Scientific's Change in Receivables history spans 7 years, with the latest figure at $117.0 million for Q1 2026.

  • On a quarterly basis, Change in Receivables rose 9.35% to $117.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $279.0 million, a 18.9% decrease, with the full-year FY2025 number at $269.0 million, down 23.36% from a year prior.
  • Change in Receivables hit $117.0 million in Q1 2026 for Boston Scientific, up from $98.0 million in the prior quarter.
  • Over the last five years, Change in Receivables for BSX hit a ceiling of $117.0 million in Q1 2026 and a floor of $3.0 million in Q3 2023.
  • Historically, Change in Receivables has averaged $70.3 million across 5 years, with a median of $75.0 million in 2023.
  • Biggest five-year swings in Change in Receivables: plummeted 78.57% in 2023 and later soared 1000.0% in 2024.
  • Tracing BSX's Change in Receivables over 5 years: stood at $44.0 million in 2022, then surged by 68.18% to $74.0 million in 2023, then rose by 21.62% to $90.0 million in 2024, then grew by 8.89% to $98.0 million in 2025, then grew by 19.39% to $117.0 million in 2026.
  • Business Quant data shows Change in Receivables for BSX at $117.0 million in Q1 2026, $98.0 million in Q4 2025, and $32.0 million in Q3 2025.